about
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.Leiomyoma of the breast: case report and review of the literature.MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancerDyskerin and TERC expression may condition survival in lung cancer patientsIntrascrotal lipoblastoma: a case report and review of the literature.Schwannoma of the breast: a case report and review of the literature.Future options for ALK-positive non-small cell lung cancer.Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer.[Primary adrenal angiosarcoma]Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis.Computer-assisted immunocytochemical determination of breast cancer steroid receptors. Frozen sections vs paraffin sections.Biopathological profile of multiple synchronous homolateral and bilateral breast cancers.Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC).Biopathologic profile of breast cancer core biopsy: is it always a valid method?Localized Intrasplenic Mesothelioma: A Case Report.IMP3 expression in non-small cell lung cancer.Scrotal calcinosis: a very rare multiple clinical presentation.Clinical outcome with platinum-based chemotherapy in patients with advanced nonsquamous EGFR wild-type non-small-cell lung cancer segregated according to KRAS mutation status.Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion gene.Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancerDuctal carcinoma in situ with microinvasion: Clinicopathologic study and biopathologic profileA population survival model for breast cancerHER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biological significanceCoexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profileCombined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues[In situ activation of metalloproteinases by the fibrinolytic system as pathogenetic mechanism of rupture of the atherosclerotic plaque]Primary mucinous carcinoma of the skinBiological prognostic factors for early stage completely resected non-small cell lung cancer[Synovial chondromatosis presenting as soft tissue mass]Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexesPrimary cutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 7 cases[Primitive angiitis of the central nervous system. An autopsy case report]Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer
P50
Q34957141-8DCF4B9D-B958-43AF-9001-772F0BE77BA9Q35668630-1E19B08B-8DB5-4602-ACF3-EE7D1BD18177Q36166125-43B216BC-49A6-4CAE-AEF0-12F5F0135205Q36356465-E1984366-DE1D-4294-99EE-57276EA1E29FQ36750500-706F6F2A-3D41-4C56-AE7B-E7493210C0EEQ36902586-44E6662A-B207-4413-B5E5-55449E369335Q38324332-D9A36042-664F-4527-BC3C-B2E107576B31Q40512867-3EFC3E19-9931-4EE8-B5B4-AE9D3164DE9EQ42465729-FBCABAB5-0C77-41C3-AAC1-78402625B649Q44432658-C02B20E2-5082-436C-A911-8E4A5D50D51CQ44627490-60E88638-0EE1-4CF7-AB10-878CECA6B426Q44673465-34DAB57E-6E12-4197-81C8-A731EBEE46C2Q44679594-91FE9FE0-EAF9-4301-B55F-B0A35374D702Q44765466-1BB53069-5C9C-405E-8682-F59811C0A0E1Q44905614-2EECD824-9442-466A-BB7E-17C42D5E0137Q45210729-95A272F0-51FB-47B7-A320-F1E8D9979002Q45216423-85B18264-8391-42C0-B827-6525DC142C8DQ46718574-BB30A93D-9792-4E9B-92F6-0431B9F4FC89Q47846842-EA91D6CD-4976-45BB-A0F6-C3AABCDF4144Q48403465-F6714E28-FE7D-441C-8E37-A1067D11C3ADQ48924508-487E1846-7DDA-43C1-A1C2-729E50A5B552Q51688636-BFECB97C-2D43-4C4E-A565-926D25A9D64DQ53351079-16B652D7-0446-4D60-9D0A-B265F76C0CC7Q53422680-3CFA1D3F-A5C0-4830-A2FD-D4680572CCD2Q53487996-EEC9899A-FCA0-4FF4-A49B-0CF6305D6881Q54384728-F657F994-C690-4999-88FB-DEE0081FD038Q57950971-9287D9EE-03C6-4E85-8306-9B71FBEEECB8Q58849638-84690D3B-9457-48E9-91BB-DCB22540BBF4Q58849647-2FFB5CB2-3662-4BD3-B879-4014CCE188ECQ61440308-F47D6607-CBF6-4B92-BB9D-3F75675DD911Q61440319-7853A010-FD44-46E0-923D-FFF82B5DB31AQ71089140-47AC2B53-B91B-46F1-A532-6A1F893147F2Q73436502-01620360-811A-47D1-94FE-64778172783EQ73688033-31E9AEC5-7912-4275-AED9-F1FA52CD96F7Q73911602-7D93F231-2F94-4070-AEEA-2580BB9A11C1Q74104348-FB05CA81-F947-4C79-8A49-83CE0ECD4246Q75401311-7D652478-66D8-4F5C-A023-A66414EE3420Q75427492-4B496EFC-CDC1-4A66-83C8-81FE0635F28EQ77920573-186BE710-A07F-4D24-AF85-E2B657662CB4Q78709824-E6DB407F-8364-4CFC-8EDB-F81D4933F7BF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Guido Bellezza
@ast
Guido Bellezza
@en
Guido Bellezza
@es
Guido Bellezza
@nl
type
label
Guido Bellezza
@ast
Guido Bellezza
@en
Guido Bellezza
@es
Guido Bellezza
@nl
prefLabel
Guido Bellezza
@ast
Guido Bellezza
@en
Guido Bellezza
@es
Guido Bellezza
@nl
P106
P31
P496
0000-0002-6337-1701